Centene Corp is primarily active in the healthcare and managed care industries.

The main competitors of Centene Corp in the market include UnitedHealth Group, Anthem Inc., Humana Inc., and CVS Health Corporation.

Centene Corp is a leading healthcare enterprise in the United States. Founded in 1984, the company has steadily grown to become a well-established player in the industry. Centene Corp focuses on providing comprehensive healthcare solutions to its members, ranging from Medicaid and Medicare programs to commercial insurance and individual insurance plans. With a strong commitment to improving access to high-quality healthcare, Centene Corp serves millions of individuals across the country. The company's history is marked by its dedication to innovation and collaboration, aiming to deliver cost-effective and patient-centered care. Centene Corp continues to evolve and expand its services, making it a prominent name in the healthcare sector.

Centene Corp has achieved significant milestones over the years. One notable achievement is its inclusion in the Fortune 500 list, which showcases the company's success and prominence. Furthermore, Centene has expanded its presence through strategic acquisitions, enhancing its market position and diversifying its offerings. The company's commitment to innovation and delivering high-quality healthcare services has earned it recognition, such as being named one of the World's Most Admired Companies in the healthcare industry. Centene Corp continues to strive for excellence, constantly seeking ways to improve patient outcomes and reshape the healthcare landscape.

Centene Corp is primarily present in the United States. As a leading healthcare enterprise, Centene operates across various states and serves millions of individuals through government-sponsored programs such as Medicaid and Medicare. With a comprehensive network of health plans and providers, Centene offers its services to diverse populations in areas including urban, rural, and underserved communities. By leveraging its expertise in managing healthcare benefits, Centene strives to improve access to quality care and enhance overall health outcomes for its members throughout the United States.

Centene Corp represents a commitment to providing high-quality healthcare services to individuals and communities in need. The company's corporate philosophy focuses on improving the health of its members by offering comprehensive, innovative, and cost-effective solutions. Centene prioritizes a patient-centric approach, ensuring access to affordable healthcare options and personalized care. With a strong emphasis on collaboration and integrity, Centene embraces diversity and inclusivity in its workforce and community partnerships. By delivering value-based care and promoting social responsibility, Centene Corp strives to improve health outcomes and enhance the overall well-being of its members and their communities.

Analysts currently set an average price target of 46.34 USD for the Centene stock (median: 43.86 USD), implying -30.9 % versus the latest price. The consensus is based on 26 analyst ratings.

Centene Analyst Price Targets 2026

26 analysts currently rate the Centene stock: 8 recommend buying, 16 holding and 2 selling. For 2026, analysts expect Centene to generate revenue of 195.91 B USD and earnings per share of 4.91 USD.

Centene Analyst Price Targets 2026

Converted at the current exchange rate, the Centene share trades at 57.57 EUR (66.40 USD).

The Centene share (CNC) is listed on 8 stock exchanges, including: NYSE (CNC), Frankfurt (QEN.F), München (QEN.MU), Düsseldorf (QEN.DU), London (0HVB.L), London (0HVB.L), SIX (Zürich) (QEN.SW).

Centene Corp is a multinational company based in the USA that specializes in providing medical services for low-income individuals. The company has been operating since 1984 and is headquartered in St. Louis, Missouri. It employs over 70,000 employees and operates in 25 US states and the international market. Centene Corp has gained a good reputation in the market and is considered a leader in the industry.

The expected revenue of Centene is 195.91 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Centene is 2.41 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Centene is currently 13.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Centene stock.

The price-to-sales ratio (P/S) of Centene is currently 0.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Centene stock.

The Eulerpool Quality Score for Centene is 3/10.

The ISIN of Centene is US15135B1017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Centene is 766458. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Centene is CNC. The ticker symbol is used to trade Centene shares on the stock exchange.

Centene paid dividends every year for the past 0 years.

Centene is assigned to the 'Health' sector.

The dividends of Centene are distributed in USD.